BSE filing, NSE: LINCOLN. Summary written from the filing by ALFA Finder's alert engine.
Lincoln Pharmaceuticals Ltd: key numbers
- Share price
- ₹499.30
- Market cap
- ₹1,000 Cr
- Revenue (annual)
- ₹671.0 Cr
- Net profit (annual)
- ₹87.89 Cr
- P/E (TTM)
- 10.3×Sector 45.9×
- Promoter holding
- 49.78%+0.00% QoQ
- FII holding
- 4.55%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Lincoln Pharmaceuticals Ltd
All →Lincoln Pharmaceuticals Q2 FY27 Results: Net Profit ₹20.4 Cr, Up 2.0% YoY
Lincoln Pharmaceuticals Ltd reported revenue from operations of ₹191.3 Cr (+17.1% YoY) and net profit of ₹20.4 Cr (+2.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹20.4 Cr · +2.0% YoY
Lincoln Pharmaceuticals Board Meeting Date
Lincoln Pharmaceuticals intimated that its Board meeting is scheduled for 29 Oct 2026 to approve Q1/H1 2026 financial results. Trading window remains closed until 48 hours after results are published.
Lincoln Pharmaceuticals Other Announcement
Lincoln Pharmaceuticals Ltd has filed its quarterly shareholding pattern statement for the period ended September 30, 2026, as required under SEBI regulations.
Lincoln Pharmaceuticals Management Change
Lincoln Pharmaceuticals Ltd announced the resignation of Mr. Pradeep Kumar Yadav, Senior General Manager - Quality Assurance, effective October 17, 2026.
Lincoln Pharmaceuticals Annual General Meeting
Lincoln Pharmaceuticals submitted the minutes and voting results of its 32nd Annual General Meeting held on September 30, 2026. The meeting concluded successfully.
Lincoln Pharmaceuticals Annual General Meeting
Lincoln Pharmaceuticals held its 32nd Annual General Meeting on September 30, 2026, where shareholders considered financial statements, dividends, and director reappointments.
Other annual report announcements
All →Bhavik Enterprises Annual Report
Bhavik Enterprises rectifies an error in Notes 3.3 and 3.4 of its FY2025-26 audited financial statements. Promoter holdings were overstated by 10,00,000 shares that were sold in the IPO offer for sale.
Dalmia Bharat Sugar and Industries Annual Report
Dalmia Bharat Sugar released its Integrated Annual Report for FY2025-26. It covers the Tanzania entry, the demerger and the Baghauli integration.
Milestone Furniture Annual Report
Milestone Furniture published its 12th Annual Report for FY2025-26 with AGM notice for 21 November 2026. Agenda covers accounts, auditor appointment, capital increase and director appointments.
CMX Holdings Annual Report
Riwind Green Energy (formerly CMX Holdings) submitted its 35th Annual Report for FY 2025-26, acknowledging a delay in filing. The AGM was held on 30 September 2026.
Aesthetik Engineers Annual Report
Aesthetik Engineers filed its Integrated Annual Report for FY2025-26 with the 18th AGM notice. The AGM will be held on November 28, 2026 via video conferencing.
Evexia Lifecare Annual Report
Evexia Lifecare filed its FY 2025-26 Annual Report ahead of its 35th AGM on 30 September 2026. It contains financial and governance disclosures, with no new transaction.